top of page

Browse by category

Search

Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy

Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy

Fractyl Health has presented new data from its preclinical Rejuva Smart GLP-1 pancreatic gene therapy program in a poster titled,...

Aardvark reveals positive data for ARD-101 in treating obesity or other metabolic conditions

Aardvark reveals positive data for ARD-101 in treating obesity or other metabolic conditions

Aardvark Therapeutics has reported positive clinical data from three Phase II trials for its lead product ARD-101, an oral small molecule...

First human implant of GLP-1 Implant NPM-115

5 days ago

Roche and Zealand Pharma to co-develop and co-commercialise petrelintide for metabolic diseases

5 days ago

Small intestine APOA4 protein could hold key to obesity treatment

5 days ago

Back to Top

bottom of page